Cell therapy for corneal disease: the future is now?
Corneal disease is one of leading causes of blindness worldwide, but new cell therapy treatments are promising hope for patients. In this video, we explore how cell therapy works and how it could revolutionize the treatment of corneal disease.
We also interviewed Greg Kunst, CEO of Aurion Biotech. Their innovative method has already been approved in Japan, and it could soon be available in the US and Europe. Kunst makes a compelling case for why cell therapy is the future of corneal disease treatment.
